drugset / Trial / NCT01033058

Intensive Statin Treatment for STEMI Patients Undergoing Primary PCI

NCT01033058 ↗

Phase 4 Unknown 500 enrolled Beijing Chao Yang Hospital Pfizer · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a retrospective, randomized, parallel, open-labeled, controlled study to find out whether STEMI patients undergoing emergency PCI can benefit from intensive atorvastatin treatment compared with routine treatment.

Timeline

Start
2009-12
Primary completion
2011-03
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 20 mg —
Comparator Atorvastatin Small molecule 40 mg —